Department of Biochemistry and Biotechnology, University of Thessaly, Larissa, Greece.
J Antimicrob Chemother. 2010 Apr;65(4):626-33. doi: 10.1093/jac/dkq039. Epub 2010 Feb 14.
Objectives Methicillin-resistant Staphylococcus aureus (MRSA) strains that express the mecA gene but are oxacillin susceptible (OS-MRSA; oxacillin MIC </=2 mg/L) are increasingly reported. To gain molecular and functional insights on this observation, we focused on additional factors possibly contributing to phenotypic susceptibility. Methods The nucleotide content of mecA, femA, femB and femX genes, which are considered essential for methicillin resistance, was determined in four OS-MRSA clinical isolates and a genetically similar low-level MRSA control (oxacillin MIC 6 mg/L). Gene expression was quantified compared with the low- and a high-level MRSA (MIC 256 mg/L) control. The tertiary structure of Fem proteins was predicted based on protein structure homology modelling, using web-based automated comparative protein modelling. Growth kinetics were tested for the study and control isolates, to determine whether FemXAB mutations lead to reduced fitness. Results Genes mecA, femA, femB and femX were expressed similarly in the study and the control isolates. Mutations in the gene mecA were not present in any isolate. However, several mutations leading to amino acid substitutions in positions possibly affecting Fem enzyme activity were detected in all fem genes. Two OS-MRSA that had no oxacillin heteroresistance had more mutations in the Fem proteins compared with the remaining isolates that were heteroresistant. The low-level MRSA control had considerably fewer mutations. No differences between growth rates of the OS-MRSA and the MRSA controls were observed. Conclusions Accumulation of amino acid changes in Fem proteins might affect intact cell wall synthesis, even though not causing reduced viability, thus contributing to atypical oxacillin responsiveness.
表达 mecA 基因但对苯唑西林敏感(OS-MRSA;苯唑西林 MIC≤2mg/L)的耐甲氧西林金黄色葡萄球菌(MRSA)菌株的报道越来越多。为了深入了解这一观察结果,我们专注于可能有助于表型敏感性的其他因素。方法:我们测定了 4 株 OS-MRSA 临床分离株和遗传上相似的低水平 MRSA 对照(苯唑西林 MIC 6mg/L)中 mecA、femA、femB 和 femX 基因的核苷酸含量,这些基因被认为对甲氧西林耐药至关重要。与低水平和高水平 MRSA(MIC 256mg/L)对照相比,定量了基因表达。使用基于蛋白质结构同源建模的网络自动化比较蛋白质建模,预测 Fem 蛋白的三级结构。为了研究和对照分离株的生长动力学,测试了是否 FemXAB 突变导致适应性降低。结果:研究和对照分离株中 mecA、femA、femB 和 femX 基因的表达相似。在任何分离株中均未发现 mecA 基因的突变。然而,在所有 fem 基因中检测到导致可能影响 Fem 酶活性的氨基酸取代的突变。没有苯唑西林异质性耐药的 2 株 OS-MRSA 的 Fem 蛋白中存在更多的突变,而具有异质性耐药的其余分离株则存在较少的突变。低水平 MRSA 对照的突变要少得多。没有观察到 OS-MRSA 和 MRSA 对照之间的生长速率差异。结论:Fem 蛋白中氨基酸变化的积累可能会影响完整细胞壁的合成,即使不会降低存活能力,从而有助于非典型的苯唑西林反应性。